Chang Yang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- Oncology top 10%
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 3
-
- RNA modifications and cancer 5
- CRISPR and Genetic Engineering 3
-
- Eosinophilic Esophagitis 3
- Xenotransplantation and immune response 3
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Gastroesophageal reflux and treatments 2
- Journals
- ACS Nano (1 paper)Journal of Materials Chemistry A (1 paper)Frontiers in Immunology (3 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Chang Yang
32 papers receiving 935 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 339
- Applied Microbiology and Biotechnology 23
- Oncology 250
- Reproductive Medicine 63
- Molecular Biology 498
Countries citing papers authored by Chang Yang
This map shows the geographic impact of Chang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Yang more than expected).
Fields of papers citing papers by Chang Yang
This network shows the impact of papers produced by Chang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Yang. The network helps show where Chang Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 23 | |
| 6 | Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapybreakdown → | 2023 | 94 |
| 7 | 2022 | 7 | |
| 8 | 2022 | 56 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 0 | |
| 13 | 2020 | 222 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 8 | |
| 16 | Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer. | 2015 | 12 |
| 17 | 2012 | 35 | |
| 18 | 2010 | 193 | |
| 19 | 2002 | 49 | |
| 20 | 2002 | 3 |
About Chang Yang
Chang Yang is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Gastroenterology, having authored 37 papers that have together received 953 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Eosinophilic Esophagitis (3 papers), CRISPR and Genetic Engineering (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Xenotransplantation and immune response (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Gastroesophageal reflux and treatments (2 papers). The work is most often cited by research in Cancer Research (339 citations), Applied Microbiology and Biotechnology (23 citations) and Oncology (250 citations). Chang Yang has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Weilin Jin, Bairong Xia, Yongjian Zhang, Ge Lou, Heng Gao, Xiao Yan Zhang, Ge Lou, Tianbo Liu, Ge Lou and Yanan Pi. Their work appears in journals such as ACS Nano, Journal of Materials Chemistry A and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.